These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 8639010)

  • 1. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [All mortality by cause of death. The challenge of coronary prevention].
    Fernández-Cruz A
    Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
    Carneiro AV; Costa J; Borges M
    Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of cholesterol-lowering medications after coronary revascularization: a population study.
    Brophy JM; Brassard P; Bourgault C
    Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the impact of fibrates and diet on survival and their cost-effectiveness: evidence from randomized, controlled trials in coronary heart disease and health economic evaluations.
    Montagne O; Vedel I; Durand-Zaleski I
    Clin Ther; 1999 Nov; 21(11):2027-35. PubMed ID: 10890271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials.
    Silberberg JS; Henry DA
    Med J Aust; 1991 Nov; 155(10):665-6, 669-70. PubMed ID: 1834922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
    Simoons ML; Casparie AF
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypercholesterolemia: to treat or not to treat? That is the question].
    Ducobu J
    Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is there a relationship between cholesterol reduction, low levels of cholesterol and mortality?].
    LaRosa JC
    Rev Esp Cardiol; 1995; 48 Suppl 2():14-7. PubMed ID: 7569270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of mortality from coronary heart disease with pravastatin.
    Tonkin AM; Ryan EW
    Biomed Pharmacother; 1999 Oct; 53(9):405-8. PubMed ID: 10554675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of lowering cholesterol on mortality].
    Schmidt JG
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2150-5. PubMed ID: 8266036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.